@article {Shishehbor681, author = {Mehdi H. Shishehbor and Tarek A. Hammad and George Thomas}, title = {Renal denervation: What happened, and why?}, volume = {84}, number = {9}, pages = {681--686}, year = {2017}, doi = {10.3949/ccjm.84a.14129}, publisher = {Cleveland Clinic Journal of Medicine}, abstract = {Despite promising results in initial trials, renal denervation failed to achieve its efficacy end points as a treatment for resistant hypertension in the SYMPLICITY HTN-3 trial, the largest trial of this treatment to date (N Engl J Med 2014; 370:1393-1401). Is renal denervation dead, or will future trials and newer technology revive it?}, issn = {0891-1150}, URL = {https://www.ccjm.org/content/84/9/681}, eprint = {https://www.ccjm.org/content/84/9/681.full.pdf}, journal = {Cleveland Clinic Journal of Medicine} }